David Happel - President & CEO, Director at Sagimet Biosciences Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President & CEO, Director
Stock Symbol
SGMT on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by David Happel since 11/22/2024

Holdings reported by David Happel for Sagimet Biosciences Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Series A Common Stock 690K $2.19M $3.18 Jul 21, 2025 Direct
Stock Option (Right to Buy) 472K Feb 6, 2025 Direct Series A Common Stock

Transactions reported by David Happel for Sagimet Biosciences Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.